Beijing Agreed CNY550mn in A-type H1N1 Flu Vaccine Storage

Posted on: Wed, 24 Jun 2009 07:52:00 EDT


Symbols: SVA
BEIJING, Jun 24, 2009 (SinoCast Daily Business Beat via COMTEX) --
SVA | Quote | Chart | News | PowerRating -- The government of Beijing has agreed to invest CNY 550 million in the storage of A-type H1N1 flu vaccines and medicines that are used to prevent and control the A-type H1N1 flu as the first batch of A-type H1N1 flu vaccines in China have been finished.

Beijing Sinovac Biotech Ltd. (AMEX:SVA), which specializes in the research, development, and production of virus vaccines, is the first company in the nation receiving A-type H1N1 flu vaccine orders, which has an annual production capacity of 20 million to 30 million pieces.

Vaccine maker Hualan Biological Engineering, Inc. (Hualan Bio, SZSE: 002007) on June 22, 2009 also announced that its A-type H1N1 flu vaccines had been finished, which are expected to come into market this September.

A pharmaceutical analyst at Goldstate Securities Co., Ltd. forecasts that consumption of the A-type H1N1 flu vaccines will surge, due to the spread-out of the flu across the world.

Source: www.cnstock.com (June 24, 2009)

For full details on Sinovac Biotech Ltd (SVA) SVA. Sinovac Biotech Ltd (SVA) has Short Term PowerRatings at TradingMarkets. Details on Sinovac Biotech Ltd (SVA) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday February 11 04:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.